USAP Reaches Agreement in Principle with Federal Trade Commission
Parties File Joint Stay Request Asking Court to Pause Case While Settlement Details Are Finalized
USAP Physician and Board Chairman
"There are uncertainties in any legal proceeding and this exceptionally prolonged litigation has required enormous time, energy, and financial commitments," said
The settlement is subject to several conditions, and any final settlement will be made without an admission of fault by USAP.
About U.S. Anesthesia Partners
U.S. Anesthesia Partners, Inc. (USAP) is a physician-owned and clinician-led organization dedicated to providing high-quality anesthesia services. USAP anesthesiologists, certified registered nurse anesthetists (CRNAs) and certified anesthesiologist assistants (CAAs) work in more than 700 facilities across the country to provide anesthesia care for more than 2 million cases annually. USAP's over 4,500 clinicians have expertise in many anesthesia subspecialties, including pediatric, cardiac and OB anesthesia. USAP's data-driven quality metrics enable continuous innovation and improvements that are shared across the organization via its national and local clinical quality network. This network helps facilitate the delivery of consistent, high-quality services for patients, surgeons, facilities, and health plans. To learn more about USAP, visit http://www.usap.com/
View original content:https://www.prnewswire.com/news-releases/usap-reaches-agreement-in-principle-with-federal-trade-commission-302752077.html
SOURCE USAP
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Weichai Power Launches World's First China VI-Compliant Heavy-Duty Hydrogen Engine, Setting a New Benchmark for Zero-Carbon Mobility
- Investeringsforeningen SparDanmark Invest suspenderer handel med alle afdelinger
- Investeringsforeningen Nykredit Invest Balance suspender handel med udvalgte afdelinger
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share